Geometry.Net - the online learning center
Home  - Health_Conditions - Congenital Facial Diplegia

e99.com Bookstore
  
Images 
Newsgroups
Page 4     61-80 of 88    Back | 1  | 2  | 3  | 4  | 5  | Next 20
A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  

         Congenital Facial Diplegia:     more detail

61. Pediatrics In Review
congenital myotonic dystrophy, also known as Steinert disease, is an autosomal life,motor function may improve significantly, although facial diplegia persists
http://medicine.ucsd.edu/peds/Pediatric Links/Links/Neurology/Hypotonia in Infan
Pediatrics in Review
Volume 17 • Number 3 • March 1996
IN BRIEF
Hypotonia in Infants
Neonatal hypotonia can have many different etiologies. Floppiness in an infant can be caused at various levels of the nervous system from disorders of the brain to spinal cord lesions, neuropathies, neuromuscular junction disorders, and myopathies. A variety of diagnostic tools are available for defining the source of the hypotonia, but before any serum values, muscle biopsies, electromyelograms (EMGs), or nerve conduction studies are ordered, a thorough neurologic examination is essential for determining the diagnosis. The first goal in diagnosing the source of neonatal hypotonia is to ascertain if it is central or peripheral. Infants who have central hypotonia from a brain source usually have other central deficits. If the child is alert, responds to surroundings, and has normal sleep-wake cycles, the hypotonia is likely to be peripheral in origin. On the other hand, if the child lacks visual tracking, appears lethargic, and has seizures or delayed milestones, it most likely is caused by a central source.
Central Hypotonia
The most common forms of neonatal floppiness are central in origin. Disorders of the developing brain that cause hypotonia include hypoxic encephalopathy, intracranial hemorrhage, infection, metabolic disorders, perinatal trauma, hypoglycemia, hypothyroidism, and chromosomal abnormalities. Infants who have central brain disorders present with a decrease in active motor strength compared with passive tone, which actually can be increased markedly. A typical infant would have poor head control and hip/shoulder weakness, but with spastic extremities. Reflexes are either normal or increased, as opposed to most peripheral causes, where the reflexes are decreased significantly.

62. Facioscapulohumeral Muscular Dystrophy (codes)
feature of this group of diseases is the congenital absence of and relatively rapidprogression and an association with facial diplegia, sensorineural deafness
http://malattierare.pediatria.unipd.it/pubblicaMR/mr_dx_ing.asp?mr=483

63. Evaluation Of Neuromuscular Disease In Children
Weakness of facial and bulbar muscles facial diplegia; ptosis; external congenitalmyotonic dystrophy; congenital myopathy; Brachial plexopathy; Mononeuropathy;
http://www.emory.edu/PEDS/NEURO/nmdz_jts.htm
Emory Pediatric Neurology Teaching Syllabus Return to the Table of Contents
Evaluation of Neuromuscular Disease in Children
John T. Sladky, M.D.
Professor of Pediatrics and Neurology
Emory University School of Medicine
Neuromuscular Disease in Children presented at the AAN 1999
The traditional approach to the topic of neuromuscular disease is to highlight constituents of the lower motor unit and discuss pathological processes that affect particular components, i.e. anterior horn cells, peripheral nerve, neuromuscular junction and muscle. Although this has proven to be a useful pedagogical strategy, it is not economical, practically or intellectually when dealing with children with neuromuscular disorders. An alternative approach is to take advantage of the fact that certain diseases present stereotypically in terms of the clinical features and the age at which they become manifest. Unlike adults, where the age of onset of symptoms may be of little help in suggesting their etiology, the age of presentation and incidence of particular disease entities in that age group can be used to structure a differential diagnosis appropriate to the age of the child.
Neuromuscular Disorders Presenting at Birth
    Clinical Features of Neuromuscular Disorders Presenting at Birth
  • Hypotonia at rest
    • No improvement in muscle tone with stimulation
    • Weakness of appendicular muscles
    • diminished grasp (palmar and plantar)
    • inability to raise limbs against gravity (or resistance)
  • Weakness of axial muscles

64. Pathology Molecular Genetics Myotonic Dystrophy
In a small proportion of cases, myotonic dystrophy may be congenital withneonatal hypotonia, motor and mental retardation, and facial diplegia.
http://www.allkids.org/Specialties/Pathology/Pages/Molecular_Genetics_Myotonic_D
INDICATIONS FOR TESTING:
Myotonic dystrophy is an autosomal dominant disorder characterized by myotonia, muscular dystrophy, cataracts, hypogonadism, frontal balding, and ECG changes. In a small proportion of cases, myotonic dystrophy may be congenital with neonatal hypotonia, motor and mental retardation, and facial diplegia. The genetic defect is an expansion of a trinucleotide pattern repeat in the 3-prime untranslated region of a protein kinase gene (DMPK) mapped to chromosome 19. Increases in clinical severity are frequently observed after parent-to-child transmission, although the severe congenital form occurs almost exclusively in the offspring of affected women. The severity of this disorder varies with the number of repeats.
TESTING OFFERED:
DNA testing measures the length of the repeated CAG pattern in the 3' untranslated region of the myotonin kinase gene. Normal individuals have from 5 to 30 repeat copies; mildly affected persons have from 50 to 80; and severely affected individuals have 2,000 or more copies.
TURN-AROUND TIME:
Most testing is completed within a time of 21 days following specimen receipt.

65. THE POSTMIGRATIONAL DEVELOPMENT OF POLYMICROGYRIA DOCUMENTED BY MAGNETIC RESONAN
congenital bilateral perisylvian polymicrogyria has become recognized as a childhoodwith the clinical features of facial diplegia, dysarthria, pseudobulbar
http://splweb.bwh.harvard.edu:8000/pages/papers/inder/postmigr/postmigr.html
THE POSTMIGRATIONAL DEVELOPMENT OF POLYMICROGYRIA DOCUMENTED BY MAGNETIC RESONANCE IMAGING FROM 31 WEEKS POSTCONCEPTIONAL AGE Terrie E. Inder, M.D. , Petra S. Huppi, M.D. , Gary P. Zientara, Ph.D. , Ferenc A. Jolesz, M.D. , Erik E. Holling, B.A. , Richard Robertson, M.D. , Patrick D. Barnes, M.D. , Joseph J. Volpe, M.D.
Department of Neurology, Children's Hospital and Harvard Medical School
Joint Program in Neonatology, Harvard Medical School and Dept. of Pediatrics, University of Geneva, Switzerland
Department of Radiology and MRI Division, Brigham and Women's Hospital, Harvard Medical School
Division of Neuroradiology, Department of Radiology, Children's Hospital and Harvard Medical School, Boston, Massachusetts.
Corresponding author:
Joseph J. Volpe, M.D.
Neurology Department
Fegan 1103,
Children's Hospital,
300 Longwood Avenue, Boston, MA 02115, USA Abstract We report the case of a 27 week premature infant in whom magnetic resonance (MR) imaging at four postnatal weeks (postconceptional age 31 weeks), term and 6 months of age documented the postnatal, postmigrational evolution of bilateral perisylvian polymicrogyria. The polymicrogyria was readily detected by ultrafine 1.5 mm coronal slices on three dimensional Fourier transformed spoiled gradient recalled (SPGR) and T2 weighted MR sequences. These MR images provide the first in-vivo documentation of the postmigrational evolution of polymicrogyria. The likelihood that the polymicrogyria was related to an ischemic, encephaloclastic mechanism is supported by the simultaneous occurrence of periventricular leukomalacia.

66. Congenital Anomalies Of The Eyelid, Orbit, And Lacrimal System
microphthalmos, ocular colobomas, and facial clefts should Blepharophimosis syndromeis a congenital syndrome of but has been associated with spastic diplegia.
http://www.ophthalmic.hyperguides.com/Tutorials/oculoplastics/congenital_anom/tu
You've spent minutes on Ophthalmic Hyperguide
Congenital Anomalies of the Eyelid, Orbit, and Lacrimal System Forrest J. Ellis, MD
Nasolacrimal Duct Obstruction
The development of the lacrimal drainage system begins at approximately 6 week's gestation. Canalization of the ectodermal cord begins during the third month in the area of the medial canthus. Canalization progresses toward the eyelid margin and toward the inferior meatus. The lacrimal puncta normally opens with eyelid separation during the seventh month of gestation. The distal lacrimal drainage system may not become patent until birth or shortly after birth. Blockage of the nasolacrimal system typically occurs in the distal portion where the tear duct opens into the nose beneath the inferior turbinate (Hasner valve). Because tears are not normally produced until a few weeks after birth, blockage of the lacrimal duct may not be recognized until several weeks after birth. Only about 1% to 6% of infants have symptomatic nasolacrimal duct obstruction. However, the majority of cases resolve by 1 year of age.

67. ATE Responses
congenital axonal neuropathy caused by deletions in the spinal muscular siblingspresented with generalized weakness, asphyxia, facial diplegia, and external
http://www.mdausa.org/experts/question.cfm?id=1085

68. Spinal Muscular Atrophy (SMA) | MDA Ask The Experts
1. Ann Neurol 1997 Sep;42(3)3648 congenital axonal neuropathy newborn siblingspresented with generalized weakness, asphyxia, facial diplegia, and external
http://www.mdausa.org/experts/ask_sma.html
Information contained in "Ask the Experts" is for informational and educational purposes only. Such information is not intended to replace, and should not be interpreted or relied upon as, professional advice, whether medical or otherwise. I have read the complete MDA Ask the Experts' , understand and agree to its terms.
Previous Experts' Responses
Ask a New Question Transcripts of Online Conferences
Summary of Previous Responses: SPINAL MUSCULAR ATROPHY (SMA) Last Updated 11/01 Approximate date of response given after each "SUBJ" below. SUBJ (11/01): HIGHER PROPENSITY FOR SKIN DISEASE I'm female, age 37 and diagnosed with spinal muscular atrophy (SMA). Do people with SMA have a higher propensity for skin diseases? I have lychens simplex chronicus and rosacea, and all of my friends that have SMA have some form of skin disorder. REPLY from MDA: Wendy Larson Peltier, M.D., MDA Clinic Director, Medical College of Wisconsin, Milwaukee, WI To my knowledge there is no association between skin disorders and spinal muscular atrophy (SMA). There may be a higher incidence, however, of certain skin disorders on the basis of being relatively immobile, or using braces or other devices that may cause chronic skin irritation. SUBJ (11/01): CONTRACTURES BETWEEN LEGS I am a 32-year-old female with spinal muscular atrophy (SMA type 2-3). I use a power wheelchair and have for many years. I have severe contractures in my hips, knees and between my legs. I would like to know more about surgery to release the contractures between my legs. I have tried Botox injections and wasn't able to continue with that treatment. It didn't seem to help anyway because it affected my muscles everywhere and was causing more weakness than I already have. If I have surgery to release just the contractures between my legs, what would that involve? How long of a recovery period should I expect? Do you think I would be able to handle the procedure satisfactorily? I don't know of any other alternatives besides surgery.

69. Myotonic Dystrophy
very mild weakness to severe and potentially fatal congenital hypotonia, and affectedfamily; testing of newborns with severe hypotonia and/or facial diplegia.
http://www.shodairhospital.org/myotonic dystrophy.htm

Contact Us
Foundation Genetics Home ... Staff Myotonic Dystrophy (DM) Mutation Testing DESCRIPTION:
  • Myotonic Dystrophy (DM), an autosomal dominant disorder with 1 in 8000 incidence, manifests as muscle wasting, myotonia, cataracts, intellectual impairment and cardiac conduction defects. DM symptoms vary widely, from very mild weakness to severe and potentially fatal congenital hypotonia, and tend to increase in severity with age and in successive generations, especially with transmission through affected females.
REASONS FOR REFERRAL:
  • Confirmation of diagnosis in a symptomatic patient; testing of children with questionable symptoms and signs in an affected family; testing of newborns with severe hypotonia and/or facial diplegia. This test detects the genetic abnormality known to cause DM: unstable CTG trinucleotide expansion in the DNA of a noncoding region of the Myotonin protein kinase gene located at chromosome 19q13.3 (Fu et al. Science 1992, 255:1256-1258).
METHOD OF ANALYSIS:
  • DNA from the patient is amplified by PCR using fluorescent primers. CTG allele sizes are determined by a high resolution laser-induced capillary electrophoresis system with internal standard.

70. ICD-9-CM International Coding Standard
343.2 congenital quadriplegia 343.3 congenital monoplegia 343.4 Quadriplegia 344.1Paraplegia 344.2 diplegia of upper 351 facial nerve disorders 351.0 Bell s
http://www.cs.umu.se/~medinfo/ICD9/icd9cm_group6.html
Diseases of the Nervous System and Sense Organs
Bacterial meningitis
    Hemophilus meningitis
    Pneumococcal meningitis
    Streptococcal meningitis
    Staphylococcal meningitis
    Meningitis in other bacterial diseases classified elsewhere
    Meningitis due to other specified bacteria
    Meningitis due to unspecified bacterium
Meningitis due to other organisms
    Cryptococcal meningitis
    Meningitis in other fungal diseases Meningitis due to viruses not elsewhere classified Meningitis due to trypanosomiasis Meningitis in sarcoidosis Meningitis due to other nonbacterial organisms classified elsewhere
Meningitis of unspecified cause
    Nonpyogenic meningitis Eosinophilic meningitis Chronic meningitis Meningitis, unspecified Encephalitis in viral diseases classified elsewhere Encephalitis in rickettsial diseases classified elsewhere Encephalitis in protozoal diseases classified elsewhere Other encephalitis due to infection classified elsewhere Encephalitis following immunization procedures Postinfectious encephalitis Toxic encephalitis Other causes of encephalitis Unspecified cause of encephalitis Intracranial abscess Intraspinal abscess
Late effects of intracranial abscess or pyogenic infection Cerebral degenerations usually manifest in childhood
    Leukodystrophy Cerebral lipidoses Cerebral degeneration in generalized lipidoses Cerebral degeneration of childhood in other diseases classified elsewhere Other specified cerebral degenerations in childhood Unspecified cerebral degeneration in childhood
Other cerebral degenerations
    Alzheimer"s disease

71. ICD-9-CM Diseases Of The Nervous System And Sense Organs Codes
3432, congenital QUADRIPLEGIA. 3433, congenital MONOPLEGIA. 3441, PARAPLEGIA NOS.3442, diplegia OF UPPER LIMBS. 351, facial NERVE DISORDERS*. 3510, BELL'S PALSY.
http://www.health.state.ok.us/program/hci/icd9v16/nervous.html
Diseases of the Nervous System and Sense Organs
* Indicates a code category. Not a valid reporting code.
Code Description BACTERIAL MENINGITIS* HEMOPHILUS MENINGITIS PNEUMOCOCCAL MENINGITIS STREPTOCOCCAL MENINGITIS STAPHYLOCOCC MENINGITIS MENING IN OTH BACT DIS BACTERIAL MENINGITIS NEC* ANAEROBIC MENINGITIS MNINGTS GRAM-NEG BCT NEC MENINGITIS OTH SPCF BACT BACTERIAL MENINGITIS NOS OTH ORGANISM MENINGITIS* CRYPTOCOCCAL MENINGITIS MENING IN OTH FUNGAL DIS MENING IN OTH VIRAL DIS TRYPANOSOMIASIS MENINGIT MENINGIT D/T SARCOIDOSIS MENING IN OTH NONBAC DIS MENINGITIS, UNSPECIFIED* NONPYOGENIC MENINGITIS EOSINOPHILIC MENINGITIS CHRONIC MENINGITIS MENINGITIS NOS ENCEPHALOMYELITIS* ENCEPHALIT IN VIRAL DIS RICKETTSIAL ENCEPHALITIS PROTOZOAL ENCEPHALITIS OTH ENCEPHALIT D/T INFEC POSTIMMUNIZAT ENCEPHALIT POSTINFECT ENCEPHALITIS TOXIC ENCEPHALITIS ENCEPHALITIS NEC ENCEPHALITIS NOS CNS ABSCESS* INTRACRANIAL ABSCESS INTRASPINAL ABSCESS CNS ABSCESS NOS PHLEBITIS INTRCRAN SINUS LATE EFF CNS ABSCESS CEREBRAL DEGEN IN CHILD* LEUKODYSTROPHY CEREBRAL LIPIDOSES CEREB DEGEN IN LIPIDOSIS CERB DEG CHLD IN OTH DIS CEREB DEGEN IN CHILD NEC CEREB DEGEN IN CHILD NOS CEREBRAL DEGENERATION* ALZHEIMER'S DISEASE PICK'S DISEASE SENILE DEGENERAT BRAIN COMMUNICAT HYDROCEPHALUS OBSTRUCTIV HYDROCEPHALUS CEREB DEGEN IN OTH DIS CEREB DEGENERATION NEC* REYE'S SYNDROME CEREB DEGENERATION NEC CEREB DEGENERATION NOS PARKINSON'S DISEASE* PARALYSIS AGITANS SECONDARY PARKINSONISM

72. [DYSPHAGIA] Polyhydramnios
An Esp Pediatr 1999 ;5138996 Steinert's congenital myotonic dystrophy and characterizedby generalized hypotonia, areflexia, facial diplegia, respiratory and
http://www.b9.com/dysphagia/2001-May/msg00370.html

73. Final Report: An Embryological Origin For Autism
autism. People with Moebius syndrome, a congenital diplegia of facialmuscles and eye abductors, have a 30% rate of autism. The
http://es.epa.gov/ncer/final/grants/95/human/rodier.html
Final Report: An Embryological Origin for Autism
EPA Grant Number:
Title:
An Embryological Origin for Autism
Investigators: Patricia M. Rodier
Institution: University of Rochester
EPA Project Officer: Dale Manty
Project Period: October 1, 1995 - September 30, 1998
Research Category: 1995 Human Health Risk Assessment
Executive Summary
Project Description: Autism spectrum disorders (ASDs) are among the most common congenital anomalies, occurring at a rate of at least 1.6 /1000 births. Little is known about the causes, and even less about the nature of the CNS injury underlying the symptoms. Family studies indicate that unknown genetic factors account for about 90% of the variance and environmental factors are also involved. In 1994, it was discovered that exposure of the closing neural tube of the human embryo to thalidomide, a well-known teratogen, could produce autism at a high rate. Valproic acid (VPA) and ethanol have been implicated as other teratogens that increase the risk of autism. Because we had been working on the same period of brain development in studies of Fetal Alcohol Syndrome and pituitary development, the thalidomide results told us many things that might be useful in studying the etiology of autism. For example, they suggested that it should be possible to model the initiating injury in animals, to demonstrate brain stem anomalies in the brains of human cases, and to find somatic evidence of early injury in patients with autism. Our objective was to test these predictions.

74. Andy Calder
To investigate this issue, we studied a group of participants with a rare congenitaldisorder that causes facial diplegia (Möbius Syndrome) (Calder, Keane
http://www.mrc-cbu.cam.ac.uk/personal/andy.calder/neuropsychology.shtml
Search for:
Neuropsychology of emotion
In addition to the researchers mentioned in each section, a number of studies have also been conducted in collaboration with Andy Young at the University of York, Dave Perrett at the University of St Andrews, and Andrew Lawrence and Jill Keane here at the CBU. Figure 1: Research summarised below discusses the involvement of the amygdala in fear processing and insula/basal ganglia regions in disgust processing. This graphic illustrates the position of these structures in the brain. Impaired recognition of fear and anger following bilateral amygdala damage A collaborative project with Sophie Scott (University College London), addressed the contribution of the amygdala to the recognition of emotion from vocal cues (Scott et al., 1997) in case DR. Results showed that DR demonstrates an identical pattern in the vocal domain (i.e., impaired recognition of vocal signals of fear and anger), supporting the view that the amygdala contributes to the recognition of these emotions across different sensory modalities (Calder et al., 2001b). This proposal is also supported by a collaborative functional imaging (fMRI) project with Mary Phillips (Institute of Psychiatry) (Phillips et al., 1998), which showed enhanced amygdala signals for facial and vocal signals of fear (see below).

75. Palsy Articles, Support Groups, And Resources
Cerebral Palsy Vs congenital Encephalopathy (Child and Neurosurgery Forum); bilateralfacial paralysis 6 genetic spastic diplegia (Neurology and Neurosurgery
http://www.medhelp.org/HealthTopics/Palsy.html
[Health Topics A-Z]
A
B C D ... Z
Palsy

[Med Help Home]
... [Patient Network] Revised: 3/30/2003

76. NIH: Health Information
Hemifacial Spasm. MelkerssonRosenthal Syndrome. Mobius Syndrome (CongenitalFacial diplegia). Parry-Romberg Syndrome. Trigeminal Neuralgia. Up to Top.
http://health.nih.gov/result.asp?disease_id=250

77. NIH: Health Information
Holoprosencephaly. MelkerssonRosenthal Syndrome. Mobius Syndrome (CongenitalFacial diplegia). Parry-Romberg Syndrome. Trigeminal Neuralgia. Up to Top.
http://health.nih.gov/result.asp?disease_id=250&category_id=6

78. ÇáËÞÇÝÉ ÇáØÈíÉ ÇáÑíÇÖíÉ
38. l MBS1 Chromosome 13q12.2q13; Dominant , or Clinical Congenitalfacial diplegia; ± Asymmetric; Ophthalmoplegia, esp VI nerve;
http://www.geocities.com/altahul/1211.htm
FACIAL NERVE (VII) PARALYSIS Anatomy
Bell's palsy

Differential diagnosis

Anatomy of facial nerve
  • 2 roots
    • Motor from facial nucleus
    • Nervus intermedius
      • Preganglionic parasympathetics (from superior salivatory nucleus)
      Major branches
      • Nerve to stapedius
      • Chorda tympani: Taste
      • Motor branches
      Bell's Palsy
      • Epidemiology
        • Lifetime prevalence: 6.4 per 1,000
        • Incidence: Increased with age
          • Overall: 0.5 per year per 1,000
          • Age 20: 0.1 per year per 1,000
          • Age 80: 0.6 per year per 1,000
          Male = Female
        • Recurrence: 7%
        • Side: Right in 63%
        Clinical Features
        • Onset
          • 3 to 72 hours
          • Pain (50%): Near mastoid process
          • Excess tearing (33%)
          • Other: Hyperacusis; Dysgeusia
          Signs
          • Stapedius dysfunction (33%)
          • Lacrimation: mildly affected in some patients
          • Taste: No clinically significant changes in most patients
          Prognosis better
          • Incomplete paralysis
          • Slow progression
          • Younger age
          • Normal salivary flow
          • Electrodiagnostic tests normal
            • Nerve excitability
            • Electrogustometry
            Treatment of Bell's palsy:
            • Corticosteroids within one week of onset
            • Prednisone 80 mg qd x 5 days; then taper over 1 week

79. C
Compulsive Gambling; @ congenital Arthromyodysplasia; @ congenital FacialDiplegia; @ congenital Heart Disease; @ congenital Nephroblastoma;
http://www.ad.com/Health/Conditions_and_Diseases/C/
search
Top
Categories:
AD.COM Web Directory is based on ODP - Open Directory Project data. No proprietary software was used in the development of this web site.
Help build the largest human-edited directory on the web. Submit a Site Open Directory Project Become an Editor

80. Searchalot Directory For Mobius Syndrome
Moebius syndrome. Mobius Syndrome Also known as congenital facialdiplegia, an information sheet compiled by NINDS. MCW Healthlink
http://www.searchalot.com/Top/Health/ConditionsandDiseases/GeneticDisorders/Mobi
Home Search News Email Greetings Weather ... Global All the Internet About AltaVista AOL Search Ask Jeeves BBC Search BBC News Business Dictionary Discovery Health Dogpile CheckDomain CNN Corbis eBay Education World Employment Encyclopedia Encarta Excite Fast Search FindLaw FirstGov Google Google Groups Infomine iWon Librarians Index Looksmart Lycos Metacrawler Microsoft Northern Light Open Directory SearchEdu SearchGov Shareware Teoma Thesaurus Thunderstone WayBackMachine Webshots WiseNut Yahoo! Yahoo! Auctions Yahoo! News Yahooligans Zeal Sponsored Links Top Health Conditions and Diseases Genetic Disorders : Mobius Syndrome Related Web Sites

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  

Page 4     61-80 of 88    Back | 1  | 2  | 3  | 4  | 5  | Next 20

free hit counter